179 related articles for article (PubMed ID: 15994144)
1. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial.
Purushotham AD; Upponi S; Klevesath MB; Bobrow L; Millar K; Myles JP; Duffy SW
J Clin Oncol; 2005 Jul; 23(19):4312-21. PubMed ID: 15994144
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Consequences of Axillary Lymph Node Dissection in the Era of Sentinel Lymph Node Biopsy for Breast Cancer.
Yen TWF; Laud PW; Pezzin LE; McGinley EL; Wozniak E; Sparapani R; Nattinger AB
Med Care; 2018 Jan; 56(1):78-84. PubMed ID: 29087982
[TBL] [Abstract][Full Text] [Related]
3. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
Mansel RE; Fallowfield L; Kissin M; Goyal A; Newcombe RG; Dixon JM; Yiangou C; Horgan K; Bundred N; Monypenny I; England D; Sibbering M; Abdullah TI; Barr L; Chetty U; Sinnett DH; Fleissig A; Clarke D; Ell PJ
J Natl Cancer Inst; 2006 May; 98(9):599-609. PubMed ID: 16670385
[TBL] [Abstract][Full Text] [Related]
4. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.
Giuliano AE; Hunt KK; Ballman KV; Beitsch PD; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; McCall LM; Morrow M
JAMA; 2011 Feb; 305(6):569-75. PubMed ID: 21304082
[TBL] [Abstract][Full Text] [Related]
5. The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope.
Thill M; Kurylcio A; Welter R; van Haasteren V; Grosse B; Berclaz G; Polkowski W; Hauser N
Breast; 2014 Apr; 23(2):175-9. PubMed ID: 24484967
[TBL] [Abstract][Full Text] [Related]
6. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function.
Hayes SC; Janda M; Cornish B; Battistutta D; Newman B
J Clin Oncol; 2008 Jul; 26(21):3536-42. PubMed ID: 18640935
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
Donker M; van Tienhoven G; Straver ME; Meijnen P; van de Velde CJ; Mansel RE; Cataliotti L; Westenberg AH; Klinkenbijl JH; Orzalesi L; Bouma WH; van der Mijle HC; Nieuwenhuijzen GA; Veltkamp SC; Slaets L; Duez NJ; de Graaf PW; van Dalen T; Marinelli A; Rijna H; Snoj M; Bundred NJ; Merkus JW; Belkacemi Y; Petignat P; Schinagl DA; Coens C; Messina CG; Bogaerts J; Rutgers EJ
Lancet Oncol; 2014 Nov; 15(12):1303-10. PubMed ID: 25439688
[TBL] [Abstract][Full Text] [Related]
8. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
Krag DN; Anderson SJ; Julian TB; Brown AM; Harlow SP; Costantino JP; Ashikaga T; Weaver DL; Mamounas EP; Jalovec LM; Frazier TG; Noyes RD; Robidoux A; Scarth HM; Wolmark N
Lancet Oncol; 2010 Oct; 11(10):927-33. PubMed ID: 20863759
[TBL] [Abstract][Full Text] [Related]
9. Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Lyman GH; Somerfield MR; Bosserman LD; Perkins CL; Weaver DL; Giuliano AE
J Clin Oncol; 2017 Feb; 35(5):561-564. PubMed ID: 27937089
[TBL] [Abstract][Full Text] [Related]
10. Prevention of seroma formation after axillary dissection--a comparative randomized clinical trial of three methods.
Kottayasamy Seenivasagam R; Gupta V; Singh G
Breast J; 2013; 19(5):478-84. PubMed ID: 23865902
[TBL] [Abstract][Full Text] [Related]
11. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
[TBL] [Abstract][Full Text] [Related]
12. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
Galimberti V; Cole BF; Zurrida S; Viale G; Luini A; Veronesi P; Baratella P; Chifu C; Sargenti M; Intra M; Gentilini O; Mastropasqua MG; Mazzarol G; Massarut S; Garbay JR; Zgajnar J; Galatius H; Recalcati A; Littlejohn D; Bamert M; Colleoni M; Price KN; Regan MM; Goldhirsch A; Coates AS; Gelber RD; Veronesi U;
Lancet Oncol; 2013 Apr; 14(4):297-305. PubMed ID: 23491275
[TBL] [Abstract][Full Text] [Related]
13. Electrical lymph node scanning (ELS) system for real-time intra-operative detection of involved axillary lymph nodes in adjuvant breast cancer patients.
Abbasvandi F; Mahdavi R; Bayat M; Hajighasemi F; Jahanbakhshi F; Aghaei F; Sami N; Khoundabi B; Ataee H; Yousefpour N; Hoseinpour P; Mousavi Kiasary SMS; Omrani Hashemi M; Shojaeian F; Akbari A; Bagherhosseini N; Moradi A; Akbari ME; Abdolahad M
Sci Rep; 2024 Jun; 14(1):12900. PubMed ID: 38839807
[TBL] [Abstract][Full Text] [Related]
14. Management of the axilla in breast cancer patients: critical review, regional modified Delphi consensus and implementation in the Tuscan breast network.
Ghilli M; Becherini C; Meattini I; Angiolini C; Bengala C; Marconi A; Galli L; Angiolucci G; Coltelli L; Borghesi S; Lastrucci L; Manca G; Bianchi S; Doria M; Casella D; Marotti L; Amunni G; Roncella M
Radiol Med; 2024 Apr; ():. PubMed ID: 38683499
[TBL] [Abstract][Full Text] [Related]
15. Prevention of Seroma Formation and Its Sequelae After Axillary Lymph Node Dissection: An Up-to-Date Systematic Review and Guideline for Surgeons.
Spiekerman van Weezelenburg MA; Bakens MJAM; Daemen JHT; Aldenhoven L; van Haaren ERM; Janssen A; Vissers YLJ; Beets GL; van Bastelaar J
Ann Surg Oncol; 2024 Mar; 31(3):1643-1652. PubMed ID: 38038792
[TBL] [Abstract][Full Text] [Related]
16. Top 100 cited classical articles in sentinel lymph nodes biopsy for breast cancer.
Liang X; Wang Y; Fu G; Fan P; Ma K; Cao XC; Lin GX; Zheng WP; Lyu PF
Front Oncol; 2023; 13():1170464. PubMed ID: 37901325
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life (HRQoL) after different axillary treatments in women with breast cancer: a 1-year longitudinal cohort study.
Vrancken Peeters NJMC; Kaplan ZLR; Clarijs ME; Mureau MAM; Verhoef C; van Dalen T; Husson O; Koppert LB
Qual Life Res; 2024 Feb; 33(2):467-479. PubMed ID: 37889384
[TBL] [Abstract][Full Text] [Related]
18. Luminal A Versus B After Choosing Wisely: Does Lymph Node Surgery Affect Oncologic Outcomes?
Ong C; Blue CM; Khan J; Deng X; Bandyopadhyay D; Louie RJ; McGuire KP
Ann Surg Oncol; 2024 Jan; 31(1):335-343. PubMed ID: 37831277
[TBL] [Abstract][Full Text] [Related]
19. Axillary Surgical Attitude Changing with Retrospective Application of
Pop CF; Nziki LD; El Helou E; Moreau M; Radermecker M; Larsimont D; Veys I; De Neubourg F
Eur J Breast Health; 2023 Oct; 19(4):318-324. PubMed ID: 37795004
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of pre-operative breast magnetic resonance imaging (MRI) in predicting axillary lymph node metastasis: variations in intrinsic subtypes, and strategy to improve negative predictive value-an analysis of 2473 invasive breast cancer patients.
Chen ST; Lai HW; Chang JH; Liao CY; Wen TC; Wu WP; Wu HK; Lin YJ; Chang YJ; Chen ST; Chen DR; Huang HI; Hung CL
Breast Cancer; 2023 Nov; 30(6):976-985. PubMed ID: 37500823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
